SGLT2 Inhibitors vs Metformin: Are Dapagliflozin, Empagliflozin, and Canagliflozin the Best First-Line Diabetes Drugs?
This article takes a deep dive into whether SGLT2 inhibitors like dapagliflozin, empagliflozin, and canagliflozin are ready to replace traditional diabetes medicines as the first-line treatment. Readers will discover how these medications stack up to older options in terms of benefits, safety, side effects, and practical tips. The article covers real-world experiences, scientific findings, and guides those considering alternatives to classic choices like Metformin.
Read More